Clinical Trial: Thrombotic RIsk FActors in AL-goneurodystrophy

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435207) titled 'Thrombotic RIsk FActors in AL-goneurodystrophy' on Feb. 20.

Brief Summary: The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Study Start Date: Jan. 26

Study Type: OBSERVATIONAL

Condition: Algoneurodystrophy

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Information provided by (Responsible Party): Laura Bogliolo, Fondazione IRCCS Policlinico San Matteo di Pavia

Disclaimer: Curated by HT Syndication....